These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Learning the value of drugs--is rofecoxib a regulatory success story? Eisenberg RS N Engl J Med; 2005 Mar; 352(13):1285-7. PubMed ID: 15800222 [No Abstract] [Full Text] [Related]
7. The Vioxx debacle revisited. Mohapatra PR; Janmeja AK Am J Med; 2005 Sep; 118(9):1058. PubMed ID: 16164909 [No Abstract] [Full Text] [Related]
8. What happened to the coxibs on the way to the cardiologist? Alberts DS; Potter JD; Martinez ME; Hess LM; Stopeck A; Lance P Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):555-6. PubMed ID: 15767326 [No Abstract] [Full Text] [Related]
9. Rofecoxib, Merck, and the FDA. Villalba L; Witter J N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625745 [No Abstract] [Full Text] [Related]
10. What are the real lessons from Vioxx? Edwards IR Drug Saf; 2005; 28(8):651-8. PubMed ID: 16048352 [No Abstract] [Full Text] [Related]
11. Drug safety special: the safety catch. Wadman M Nature; 2005 Mar; 434(7033):554-6. PubMed ID: 15800591 [No Abstract] [Full Text] [Related]
12. Drug safety and regulation. Waller PC; Evans SJ; Beard K BMJ; 2005 Jul; 331(7507):4-5. PubMed ID: 15994664 [No Abstract] [Full Text] [Related]
13. What ails the FDA? Okie S N Engl J Med; 2005 Mar; 352(11):1063-6. PubMed ID: 15784660 [No Abstract] [Full Text] [Related]
14. Vioxx's history and the need for better procedures and better testing. Gilhooley M Seton Hall Law Rev; 2007; 37(4):941-68. PubMed ID: 18363218 [No Abstract] [Full Text] [Related]
15. Coxibs and cardiovascular disease. Fitzgerald GA N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192 [No Abstract] [Full Text] [Related]
16. Failing the public health--rofecoxib, Merck, and the FDA. Topol EJ N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193 [No Abstract] [Full Text] [Related]
17. The Vioxx debacle. Alpert JS Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713 [No Abstract] [Full Text] [Related]
18. Cyclooxygenase-2 inhibitors and cardiovascular risk. Smith ER Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124 [No Abstract] [Full Text] [Related]
19. The Vioxx fallout. Palmer K Minn Med; 2005 Mar; 88(3):26-30. PubMed ID: 15852592 [No Abstract] [Full Text] [Related]
20. [Cyclooxygenase inhibitors: a never ending story?]. Macrì R; Manfredi C G Ital Cardiol (Rome); 2006 Jul; 7(7):505-7. PubMed ID: 16977790 [No Abstract] [Full Text] [Related] [Next] [New Search]